相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT1R upregulation are required for doxorubicin-induced cardiotoxicity
Chih-Yang Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy
Chih-Yang Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways
Fan Tang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy
Michael Mutlak et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling, and stimulate Ca2+-dependent signaling
Paul Robinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Trastuzumab cardiotoxicity: from clinical trials to experimental studies
Balazs T. Nemeth et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Activation of IGF-1 receptors and Akt signaling by systemic hyperinsulinemia contributes to cardiac hypertrophy but does not regulate cardiac autophagy in obese diabetic mice
Karla Maria Pires et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Shift toward greater pathologic post-myocardial infarction remodeling with loss of the adaptive hypertrophic signaling of alpha1 adrenergic receptors in mice
Che-Chung Yeh et al.
PLOS ONE (2017)
Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy
Erin M. Higgins et al.
JCI INSIGHT (2017)
Icariin attenuated oxidative stress induced-cardiac apoptosis by mitochondria protection and ERK activation
Yao-Hong Song et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy
Jennifer Davis et al.
CELL (2016)
Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
Kesong Peng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib
Valentina Sala et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Analyzing ERK 1/2 signalling and targets
Alexandra Brietz et al.
MOLECULAR BIOSYSTEMS (2016)
Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human Cardiomyocytes
Nishant Mohan et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Scaffold Proteins Regulating Extracellular Regulated Kinase Function in Cardiac Hypertrophy and Disease
Yan Liang et al.
FRONTIERS IN PHARMACOLOGY (2016)
Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway
Chen Li et al.
PLOS ONE (2016)
Roles of FGF Signals in Heart Development, Health, and Disease
Nobuyuki Itoh et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy
Lin Zhong et al.
CARDIOVASCULAR RESEARCH (2015)
Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes
Mi-Hua Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt
Shu-Fang He et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Luc Rochette et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Cardiac-targeting magnetic lipoplex delivery of SH-IGF1R plasmid attenuate norepinephrine-induced cardiac hypertrophy in murine heart
Yiping Xu et al.
BIOSCIENCE REPORTS (2014)
Inherited Cardiomyopathies
Jeffrey A. Towbin
CIRCULATION JOURNAL (2014)
Doxorubicin and Trastuzumab Regimen Induces Biventricular Failure in Mice
Giuseppina Milano et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)
The Muscle Ankyrin Repeat Proteins CARP, Ankrd2, and DARP Are Not Essential for Normal Cardiac Development and Function at Basal Conditions and in Response to Pressure Overload
Marie-Louise Bang et al.
PLOS ONE (2014)
Erbin is a negative modulator of cardiac hypertrophy
Inbal Rachmin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Met signaling in cardiomyocytes is required for normal cardiac function in adult mice
Maria Arechederra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
The Dual-Targeted HER1/HER2 Tyrosine Kinase Inhibitor Lapatinib Strongly Potentiates the Cardiac Myocyte-Damaging Effects of Doxorubicin
Brian B. Hasinoff et al.
CARDIOVASCULAR TOXICOLOGY (2013)
Loss of Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells and Cardiomyocytes Causes Arterial Hypotension and Cardiac Hypertrophy
Barbara Schreier et al.
HYPERTENSION (2013)
beta 2-AR-induced Her2 transactivation mediated by Erbin confers protection from apoptosis in cardiomyocytes
Ming Shi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Molecular basis of physiological heart growth: fundamental concepts and new players
Marjorie Maillet et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Fibroblast Growth Factor Receptor 1 Signaling in Adult Cardiomyocytes Increases Contractility and Results in a Hypertrophic Cardiomyopathy
Sarah N. Cilvik et al.
PLOS ONE (2013)
Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy
Catharina Ruppert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Molecular Mechanism of beta-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Eric Reiter et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
β-Adrenergic receptor stimulation causes cardiac hypertrophy via a G/Erk-dependent pathway
Marie Vidal et al.
CARDIOVASCULAR RESEARCH (2012)
Urotensin II prevents cardiomyocyte apoptosis induced by doxorubicin via Akt and ERK
Yen-Ling Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Signaling to Cardiac Hypertrophy: Insights from Human and Mouse RASopathies
Valentina Sala et al.
MOLECULAR MEDICINE (2012)
Cardiac-Specific Over-Expression of Epidermal Growth Factor Receptor 2 (ErbB2) Induces Pro-Survival Pathways and Hypertrophic Cardiomyopathy in Mice
Polina Sysa-Shah et al.
PLOS ONE (2012)
IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload
Mauro Sbroggio et al.
CARDIOVASCULAR RESEARCH (2011)
Morgana and Melusin Two fairies chaperoning signal transduction
Roberta Ferretti et al.
CELL CYCLE (2011)
MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation
Xue Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Activated Met Signalling in the Developing Mouse Heart Leads to Cardiac Disease
Christian Leo et al.
PLOS ONE (2011)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation
Izhak Kehat et al.
CIRCULATION (2010)
Targeted Deletion of the Extracellular Signal-Regulated Protein Kinase 5 Attenuates Hypertrophic Response and Promotes Pressure Overload-Induced Apoptosis in the Heart
Tomomi E. Kimura et al.
CIRCULATION RESEARCH (2010)
Molecular and Clinical Analysis of RAF1 in Noonan Syndrome and Related Disorders: Dephosphorylation of Serine 259 as the Essential Mechanism for Mutant Activation
Tomoko Kobayashi et al.
HUMAN MUTATION (2010)
Protein Kinase C Epsilon-Dependent Extracellular Signal-Regulated Kinase 5 Phosphorylation and Nuclear Translocation Involved in Cardiomyocyte Hypertrophy With Angiotensin II Stimulation
Zhuo Zhao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Protein scaffolds in MAP kinase signalling
Matthew D. Brown et al.
CELLULAR SIGNALLING (2009)
Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure
Xiao-Mei Li et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
Kristina Lorenz et al.
NATURE MEDICINE (2009)
Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal -: Regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways
Maria I. Kontaridis et al.
CIRCULATION (2008)
Beta-Arrestin-Mediated Signaling in the Heart
Priyesh A. Patel et al.
CIRCULATION JOURNAL (2008)
An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice
Farah Sheikh et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Mechanisms of disease: Cardiac plasticity
Joseph A. Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Il-Man Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics
Ronny Alcalai et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2008)
Mitogen-activated protein kinases in heart development and diseases
Yibin Wang
CIRCULATION (2007)
b-arrestin-mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Takahisa Noma et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo
Nicole H. Purcell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Bhaswati Pandit et al.
NATURE GENETICS (2007)
In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice
Nancy Gerits et al.
TRANSGENIC RESEARCH (2007)
Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats
Li-Mien Chen et al.
EXPERIMENTAL PHYSIOLOGY (2007)
Cardiac GPCRs: GPCR signaling in healthy and failing hearts
Natasha C. Salazar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Contemporary definitions and classification of the cardiomyopathies - An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; And Council on Epidemiology and Prevention
BJ Maron et al.
CIRCULATION (2006)
β-arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor
SK Shenoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Integrin signalling: The tug-of-war in heart hypertrophy
Mara Brancaccio et al.
CARDIOVASCULAR RESEARCH (2006)
Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq/Gαi coupling causes hypertrophy and bradycardia in transgenic mice
PY Zhai et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload
M De Acetis et al.
CIRCULATION RESEARCH (2005)
Transduction of receptor signals by β-arrestins
RJ Leftowitz et al.
SCIENCE (2005)
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy
H Lou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by β-arrestins 1 and 2
S Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Stress-activated MAP kinases in cardiac remodeling and heart failure new insights from transgenic studies
BG Petrich et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2004)
Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence
G Selvetella et al.
CARDIOVASCULAR RESEARCH (2004)
Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload
IS Harris et al.
CIRCULATION (2004)
MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol
AM Domina et al.
ONCOGENE (2004)
Signaling through the extracellular signal-regulated kinase 1/2 cascade in cardiac myocytes
A Clerk et al.
BIOCHEMISTRY AND CELL BIOLOGY (2004)
Activation of big MAP kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischernia and reperfusion
SJ Cameron et al.
FEBS LETTERS (2004)
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
A Aries et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt
R Fukazawa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK
LA Allan et al.
NATURE CELL BIOLOGY (2003)
The α1A/C- and α1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse
TD O'Connell et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Melusin, a muscle-specific integrin beta(1)-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload
M Brancaccio et al.
NATURE MEDICINE (2003)
Regulation of map kinase signaling modules by scaffold proteins in mammals
DK Morrison et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2003)
Cardiac hypertrophy: The good, the bad and the ugly
N Frey et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation
SC Biswas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation
J Garcia et al.
EMBO JOURNAL (2002)
αl-Adrenergic activation of the cardiac ankyrin repeat protein gene in cardiac myocytes
T Maeda et al.
GENE (2002)
Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense
S Kagiyama et al.
CIRCULATION (2002)
ErbB2 is essential in the prevention of dilated cardiomyopathy
SA Crone et al.
NATURE MEDICINE (2002)
The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1-and 2-mediated phosphorylation of serine 105 in cardiomyocytes
QR Liang et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy
RL Nicol et al.
EMBO JOURNAL (2001)
MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors
SEF Tran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cardiac mechanotransduction:: from sensing to disease and treatment
P Tavi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking
WE Miller et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
Prognostic implications of left ventricular hypertrophy
BA Vakili et al.
AMERICAN HEART JOURNAL (2001)
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
LM Luttrell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
OF Bueno et al.
EMBO JOURNAL (2000)
Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling
P Paradis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Genetic dissection of cardiac growth control pathways
WR MacLellan et al.
ANNUAL REVIEW OF PHYSIOLOGY (2000)
Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice
C Pellieux et al.
JOURNAL OF HYPERTENSION (2000)
分享论文
